I. National Institution Drug Abuse (NIDA) announces two Challenges/Prize Competitions for research and non-research communities, and encourages potential applicants-Solvers to examine the announcements and to submit the proposals.
II. Request for Applications (RFA) for Substance Use Disorders and Molecular Regulation of Brain Energy Utilization
III. Funding Opportunity Announcement for "Mechanisms of Alcohol and Nicotine Co-Addiction."
---------------------------------------------------------------------------------------------------------------------
I. National Institution Drug Abuse (NIDA) announces two Challenges/Prize Competitions for research and non-research communities, and encourages potential applicants-Solvers to examine the announcements and to submit the proposals:
1) Help to find a way to reduce or eliminate the risk of harm from accidentally or intentionally swallowing too many pain prescription pills at the same time. Participate in NIDA Challenge "Propose New Ideas for Prescription Drugs Oral Overdose Protection" http://preventoverdose.challenge.gov/
Additional information: http://www.gpo.gov/fdsys/pkg/FR-2013-05-16/html/2013-11689.htm
2) Using primary data sources relevant to substance use and abuse, create an infographic to inform and educate the general public in interesting, novel, and creative ways about prescription drug abuse dangers. Participate in NIDA Challenge "Data Rx: Prescription Drug Abuse Infographic Challenge" http://data-rx.challenge.gov/
Additional information: http://www.gpo.gov/fdsys/pkg/FR-2013-05-16/html/2013-11688.htm
For more information contact:
Elena Koustova, PhD, MBA
NIDA Challenge Manager
6001 Executive Blvd
Bethesda, MD 20892
301-496-8768
koustovae@nida.nih.gov
--------------------------------------------------------------------------------------------------------------------
II. Request for Applications (RFA) for "Substance Use Disorders and Molecular Regulation of Brain Energy Utilization"
The National Institute on Drug Abuse intends to commit $2 million per year to fund approximately 3-5 R21 (RFA-DA-14-006) and 2-3 R01 (RFA-DA-14-005) awards beginning in FY 2014. The purpose of these funding opportunities is to support projects investigating the interplay between molecular regulation of brain energy utilization and brain and/or behavioral changes resulting from chronic exposure to abused substances. Applicants MUST focus their applications on one or more substances of abuse (e.g. nicotine, stimulants, opioids, cannabinoids, inhalants, abused prescription medicines, psychedelic drugs, caffeine, etc.). Studies investigating chronic, rather than acute, exposure to abused substances and studies involving drug withdrawal, reinstatement, or related paradigms are of particular interest. Investigators with limited experience in substance abuse research are encouraged to collaborate with researchers that have substance abuse expertise. Applications submitted to this FOA also MUST have a primary focus on molecular mechanisms regulating brain energy utilization. As a consequence, it is anticipated that most applicants will choose to exploit biological systems in which brain material is available for molecular analyses. Researchers with interesting observations on brain energy utilization in human subjects may wish to collaborate with researchers with access to the appropriate tissues to investigate their hypotheses at the molecular level.
- Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R01)
(RFA-DA-14-005)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2013 - Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R21)
(RFA-DA-14-006)
National Institute on Drug Abuse
Application Receipt Date(s): August 15, 2013
For further information contact:
Kristopher Bough, PhD
National Institute on Drug Abuse
Telephone: 301-443-9800
Email: boughk@mail.nih.gov
-------------------------------------------------------------------------------------------------------------------------------
III. Funding Opportunity Anouncement for "Mechanisms of Alcohol and Nicotine Co-Addiction."
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA) encourages grant applications to examine mechanisms contributing to concurrent alcohol and nicotine dependence. Co-occurring alcohol and nicotine dependence is common. Research suggests that alcohol dependence and nicotine dependence have similar genetic, neurochemical and behavioral characteristics. It is not well understood, however, whether common mechanisms underlie the comorbidity of alcohol and nicotine use and dependence. The purpose of this funding opportunity announcement is to promote research to study neurobiological and behavioral mechanisms of dependence and how alcohol and nicotine use interact through these mechanisms to promote dependence. Such an understanding is essential to guide the development of better prevention and treatment strategies for alcohol and nicotine co-abuse.
· Mechanisms of Alcohol and Nicotine Co-Addiction (R01) PA-13-194 and NOT-DA-13-024
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Application Receipt Date(s): Standard dates apply; earliest receipt date Sept 5, 2013.
· Mechanisms of Alcohol and Nicotine Co-Addiction (R21) PA-13-193 and NOT-DA-13-025
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Application Receipt Date(s): Standard dates apply; earliest receipt date Sept 5, 2013.
For further information, contact:
Susan Volman, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-435-1315
Email: svolman@nida.nih.gov
---------------------------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih. Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
